Related Experiment Videos
High-density lipoproteins, reverse cholesterol transport and atherosclerosis--recent developments
Insights
High-density lipoproteins (HDL) transport cholesterol from tissues, playing a key role in reverse cholesterol transport. Accurate HDL cholesterol measurement aids in identifying patients at risk for coronary artery atherosclerosis.
Area of Science:
- Cardiovascular Biochemistry
- Lipid Metabolism
- Atherosclerosis Research
Background:
- High-density lipoproteins (HDL) transport approximately 33% of plasma cholesterol.
- HDL is crucial for cholesterol efflux and redistribution from non-hepatic tissues.
- HDL's role in reverse cholesterol transport is linked to lower atherosclerosis prevalence.
Purpose of the Study:
- To highlight the significance of HDL in reverse cholesterol transport.
- To discuss the potential of HDL and reverse cholesterol transport in predicting coronary artery atherosclerosis.
- To emphasize the clinical utility of HDL cholesterol assays in risk assessment.
Main Methods:
- Review of current understanding of HDL biochemistry and reverse cholesterol transport.
- Analysis of the relationship between HDL levels and atherosclerosis.
- Evaluation of HDL cholesterol assays for clinical application.
Main Results:
- HDL plays a central role in reverse cholesterol transport.
- Advances in HDL research offer potential for improved atherosclerosis prognostication.
- Current advanced methods are primarily research-based.
Conclusions:
- Accurate HDL cholesterol assays, when interpreted with total and LDL cholesterol, can help identify at-risk patients.
- HDL cholesterol measurement is a valuable tool for recognizing individuals susceptible to premature coronary artery atherosclerosis.
- Further research into HDL and reverse cholesterol transport may yield more powerful prognostic markers.
Abstract:
High-density lipoproteins (HDLs) carry about 33% of the plasma cholesterol, while most of the remainder is carried by the low-density lipoprotein (LDL) fraction. The former appears to be associated with the efflux and redistribution of cholesterol present in non-hepatic tissues. In consequence, HDL is thought to play a prominent role in reverse cholesterol transport, which may be the basis for the negative association between plasma HDL levels and the prevalence of atherosclerosis within populations. Recent advances in the biochemistry of HDL and reverse cholesterol transport offer new hope of providing more powerful prognostic indices of the likelihood of premature coronary artery atherosclerosis in the individual. Currently, however, these new approaches are limited to research centres. An accurate HDL cholesterol assay, interpreted in the light of total cholesterol and particularly the atherogenic LDL fraction, is nevertheless capable of assisting in the recognition of the at-risk patient.